These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 6117627

  • 1. Antidiarrhoeal effects of quipazine and l-(m-trifluoromethylphenyl)piperazine in mice.
    Warrick MW, Dinwiddie WG, Lin TM, Fuller RW.
    J Pharm Pharmacol; 1981 Oct; 33(10):675-6. PubMed ID: 6117627
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Neurochemical analysis of the mechanism of action of serotoninergic substances on avoidance behavior in situations of acute stress].
    Shelekhov SL, Val'dman AV.
    Biull Eksp Biol Med; 1984 Apr; 97(4):423-6. PubMed ID: 6232963
    [Abstract] [Full Text] [Related]

  • 5. Antagonism by methysergide of the effects of L-5-hydroxytryptophan and quipazine on schedule-controlled responding.
    Leander JD.
    Neuropharmacology; 1981 Dec; 20(12A):1141-3. PubMed ID: 6976522
    [No Abstract] [Full Text] [Related]

  • 6. 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.
    Glennon RA, Slusher RM, Lyon RA, Titeler M, McKenney JD.
    J Med Chem; 1986 Nov; 29(11):2375-80. PubMed ID: 3783595
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM, Gala RR.
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract] [Full Text] [Related]

  • 9. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Meyer JS, Buckholtz NS, Boggan WO.
    Neuroendocrinology; 1978 Mar; 26(5):312-24. PubMed ID: 150549
    [Abstract] [Full Text] [Related]

  • 10. Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.
    Lucki I, Minugh-Purvis N.
    Brain Res; 1987 Sep 15; 420(2):403-6. PubMed ID: 2960422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antinociceptive comparison of quipazine and morphine.
    Minnema DJ, DeWitt L, Rosecrans JA.
    Commun Psychopharmacol; 1980 Sep 15; 4(2):115-20. PubMed ID: 7428332
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR, Nash HL, Preston PR, Wallis DI.
    Br J Pharmacol; 1979 May 15; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract] [Full Text] [Related]

  • 16. Serotonin-like actions of quipazine on the central nervous system.
    Rodríguez R, Rojas-Ramírez JA, Drucker-Colín RR.
    Eur J Pharmacol; 1973 Nov 15; 24(2):164-71. PubMed ID: 4543615
    [No Abstract] [Full Text] [Related]

  • 17. [Pharmacological properties of indolylalkyl derivatives of quipazine].
    Trubitsyna TK, Kashkovskiĭ MD.
    Farmakol Toksikol; 1980 Nov 15; 43(5):530-6. PubMed ID: 7449980
    [Abstract] [Full Text] [Related]

  • 18. Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats.
    Hemrick-Luecke SK, Fuller RW.
    Biochem Pharmacol; 1995 Jan 31; 49(3):323-7. PubMed ID: 7857319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK, Asnina VV, Mashkovskiĭ MD.
    Farmakol Toksikol; 1986 Jan 31; 49(1):44-9. PubMed ID: 3948987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.